Napaporn Chantasrisawad

Bangkok, 10330, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Beyond the first breath: comprehensive respiratory syncytial virus prevention through maternal immunization and infant immunoprophylaxis.

Beyond the first breath: comprehensive respiratory syncytial virus prevention through maternal immunization and infant immunoprophylaxis.

Journal: Asian biomedicine : research, reviews and news

Published: July 30, 2025

Seroprevalence and preventive practices of dengue and chikungunya among school children in Bangkok: Gaps in prevention and vaccination strategies.

Seroprevalence and preventive practices of dengue and chikungunya among school children in Bangkok: Gaps in prevention and vaccination strategies.

Journal: PLoS neglected tropical diseases

Published: April 10, 2025

Multimodal intervention to decrease central line-associated bloodstream infection rate in pediatric intensive care unit.

Multimodal intervention to decrease central line-associated bloodstream infection rate in pediatric intensive care unit.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: March 12, 2025

Characterization of Clinical and Biologic Manifestations of Chikungunya Among Children in an Urban Area, Thailand: A Retrospective Cohort Study.

Characterization of Clinical and Biologic Manifestations of Chikungunya Among Children in an Urban Area, Thailand: A Retrospective Cohort Study.

Journal: The Pediatric infectious disease journal

Published: September 04, 2024

Global COVID-19 Vaccination in Infants and Children: Effectiveness, Safety, and Challenges.

Global COVID-19 Vaccination in Infants and Children: Effectiveness, Safety, and Challenges.

Journal: Asian Pacific journal of allergy and immunology

Published: October 24, 2023

High Transmission Rates of Early Omicron Subvariant BA.2 in Bangkok, Thailand.

High Transmission Rates of Early Omicron Subvariant BA.2 in Bangkok, Thailand.

Journal: Advances in virology

Published: September 01, 2023

Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children.

Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children.

Journal: Vaccine: X

Published: June 19, 2023

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.

Journal: Vaccine

Published: May 11, 2023

Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance.

Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance.

Journal: Vaccine: X

Published: April 12, 2023

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 01, 2022

Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents.

Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents.

Journal: Vaccines

Published: September 02, 2022

Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster.

Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster.

Journal: Vaccine: X

Published: June 29, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026